Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDORMS researchers have been awarded funding from the Chan Zuckerberg Initiative to ensure that tendon samples from understudied ethnic groups are included in the Tendon Human Cell Atlas.

Montage of human faces © Gerd Altmann from Pixabay

Tendons are essential for all forms of movement but are prone to inflammation and tears, causing pain and loss of mobility for patients. As part of an international partnership, NDORMS researchers have been mapping the cells present in healthy human tendons across anatomical sites in the body for over the past year. By creating a dataset for healthy tendon cell types to input into the Human Cell Atlas, they are developing a molecular map that will provide a resource to understand tendon disease and to advance treatments.

The team has recently been awarded additional funding by the Chan Zuckerberg Initiative that ensures samples of tendon from ethnically underrepresented donors can be collected and mapped. The curation of an ethnically diverse database is fundamental to ensuring that future benefits are equitably distributed.

Sarah Snelling, Associate Professor at NDORMS and lead investigator of The Tendon Seed Network says: "This funding will allow us to build ethnic diversity into the Tendon Cell Atlas. By working with Prof Xavier Griffin (London) and Prof Chris Buckley (Birmingham/Oxford), we will expand the atlas to capture the cells present in the tendons of donors from underrepresented ethnic groups and ensure we deliver a robust cell atlas of tendon that better represents global populations."

A challenge for researchers has been the social and cultural barriers to participation found in different minority groups. "We will work with our patient involvement and engagement teams to better understand barriers to participation in research for minority ethnic groups and work with these communities to support their future participation," explained Dr Mathew Baldwin who is the clinical co-lead on the project.

Their goal is to collect healthy tendon tissue samples from Asian and Black patients, ensuring that over one third of the anatomical tendon sites profiled by the Tendon Seed Network will be from donors from ethnically understudied populations.

Norbert Tavares, Chan Zuckerberg Initiative Program Manager for Single-Cell Biology, said: "It is critical to include diverse tissue samples in the Human Cell Atlas so we can learn and grow from historical shortcomings and bias in genomics. While this effort is only the start of addressing diversity in the Human Cell Atlas in the long term, these projects will serve as an initial pilot to surface future opportunities to more deeply address these challenges for the future."

FUNDED BY

Chan Zuckerberg Initiative logo

Similar stories

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.